These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29779010)

  • 1. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjögren's Syndrome.
    Gourzi VC; Kapsogeorgou EK; Kyriakidis NC; Tzioufas AG
    Clin Exp Immunol; 2015 Oct; 182(1):14-22. PubMed ID: 26201309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of miR200b-5p miRNA in lymphomagenesis associated with Sjögren's syndrome (SS).
    Kapsogeorgou EK; Tzioufas AG
    Mediterr J Rheumatol; 2018 Mar; 29(1):56-58. PubMed ID: 32185300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive markers of lymphomagenesis in Sjögren's syndrome: From clinical data to molecular stratification.
    Kapsogeorgou EK; Voulgarelis M; Tzioufas AG
    J Autoimmun; 2019 Nov; 104():102316. PubMed ID: 31431317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
    Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
    Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectopic Germinal Center-Like Structures in Minor Salivary Gland Biopsy Tissue Predict Lymphoma Occurrence in Patients With Primary Sjögren's Syndrome.
    Sène D; Ismael S; Forien M; Charlotte F; Kaci R; Cacoub P; Diallo A; Dieudé P; Lioté F
    Arthritis Rheumatol; 2018 Sep; 70(9):1481-1488. PubMed ID: 29669392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma development in Sjögren's syndrome: novel p53 mutations.
    Tapinos NI; Polihronis M; Moutsopoulos HM
    Arthritis Rheum; 1999 Jul; 42(7):1466-72. PubMed ID: 10403275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the outcome of Sjogren's syndrome-associated non-hodgkin's lymphoma patients.
    Papageorgiou A; Ziogas DC; Mavragani CP; Zintzaras E; Tzioufas AG; Moutsopoulos HM; Voulgarelis M
    PLoS One; 2015; 10(2):e0116189. PubMed ID: 25723713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren's syndrome.
    Theander E; Vasaitis L; Baecklund E; Nordmark G; Warfvinge G; Liedholm R; Brokstad K; Jonsson R; Jonsson MV
    Ann Rheum Dis; 2011 Aug; 70(8):1363-8. PubMed ID: 21715359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective regulation of L1 endogenous retroelements in primary Sjogren's syndrome and systemic lupus erythematosus: Role of methylating enzymes.
    Mavragani CP; Nezos A; Sagalovskiy I; Seshan S; Kirou KA; Crow MK
    J Autoimmun; 2018 Mar; 88():75-82. PubMed ID: 29074164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sjögren's syndrome associated with non-Hodgkin's lymphoma].
    Nagai K
    Nihon Rinsho; 1995 Oct; 53(10):2574-9. PubMed ID: 8531376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the risk for lymphoma development in Sjogren syndrome: An easy tool for clinical use.
    Fragkioudaki S; Mavragani CP; Moutsopoulos HM
    Medicine (Baltimore); 2016 Jun; 95(25):e3766. PubMed ID: 27336863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I Interferon Dependent hsa-miR-145-5p Downregulation Modulates MUC1 and TLR4 Overexpression in Salivary Glands From Sjögren's Syndrome Patients.
    Jara D; Carvajal P; Castro I; Barrera MJ; Aguilera S; González S; Molina C; Hermoso M; González MJ
    Front Immunol; 2021; 12():685837. PubMed ID: 34149728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The P2X7 receptor-NLRP3 inflammasome complex predicts the development of non-Hodgkin's lymphoma in Sjogren's syndrome: a prospective, observational, single-centre study.
    Baldini C; Santini E; Rossi C; Donati V; Solini A
    J Intern Med; 2017 Aug; 282(2):175-186. PubMed ID: 28503820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome.
    Alevizos I; Alexander S; Turner RJ; Illei GG
    Arthritis Rheum; 2011 Feb; 63(2):535-44. PubMed ID: 21280008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Cell Activation Biomarkers in Salivary Glands Are Related to Lymphomagenesis in Primary Sjögren's Disease: A Pilot Monocentric Exploratory Study.
    Bruno D; Tolusso B; Lugli G; Di Mario C; Petricca L; Perniola S; Bui L; Benvenuto R; Ferraccioli G; Alivernini S; Gremese E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A biomarker for lymphoma development in Sjogren's syndrome: Salivary gland focus score.
    Chatzis L; Goules AV; Pezoulas V; Baldini C; Gandolfo S; Skopouli FN; Exarchos TP; Kapsogeorgou EK; Donati V; Voulgari PV; Mavragani CP; Gorgoulis V; De Vita S; Fotiadis D; Voulgarelis M; Moutsopoulos HM; Tzioufas AG
    J Autoimmun; 2021 Jul; 121():102648. PubMed ID: 34029875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein-Associated Phospholipase A2: A Novel Contributor in Sjögren's Syndrome-Related Lymphoma?
    Nezos A; Skarlis C; Psarrou A; Markakis K; Garantziotis P; Papanikolaou A; Gravani F; Voulgarelis M; Tzioufas AG; Koutsilieris M; Moutsopoulos HM; Kotsifaki E; Mavragani CP
    Front Immunol; 2021; 12():683623. PubMed ID: 34220834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of infiltration by macrophages and dendritic cells and expression of interleukin-18 and interleukin-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development.
    Manoussakis MN; Boiu S; Korkolopoulou P; Kapsogeorgou EK; Kavantzas N; Ziakas P; Patsouris E; Moutsopoulos HM
    Arthritis Rheum; 2007 Dec; 56(12):3977-88. PubMed ID: 18050195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.